Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
Breast Imaging
CV
Chest
Emergency
GI
GU
Head & Neck
Interventional
Physics
MSK
Neuro
Nuclear
Pediatric
Radiation Oncology
Genitourinary Radiology: Page 21
Radiology volume, research will take COVID-19 hit
By
Kate Madden Yee
The COVID-19 pandemic will adversely affect imaging volume, cancer treatment, and research going forward, according to a series of reports published April 15 in
Radiology
and
Radiology: Imaging Cancer
.
April 15, 2020
SABR slows prostate cancer progression
By
Kate Madden Yee
A form of highly focused, intense radiation therapy called stereotactic ablative radiation (SABR) appears to slow the progression of metastatic prostate cancer in men with hormone-sensitive disease, according to a study published online March 26 in
JAMA Oncology
.
March 26, 2020
PSMA-PET/CT again shows prowess for prostate cancer
By
Wayne Forrest
Prostate-specific membrane antigen (PMSA)-PET/CT could become the primary modality approach in confirming the extent of prostate cancer and the most efficient way to direct patients to the most appropriate treatment, according to a study published March 22 in the
Lancet
.
March 24, 2020
Blue Earth launches phase III trial for PET agent
By
AuntMinnie.com staff writers
Bracco molecular imaging subsidiary Blue Earth Diagnostics said that a phase III clinical trial of its investigational radiohybrid PET imaging agent for prostate cancer is now underway.
March 16, 2020
MRI-targeted biopsy optimizes prostate cancer detection
By
Wayne Forrest
MRI-targeted biopsy can greatly improve prostate cancer diagnosis and reduce the chances of patients being either overtreated or undertreated for their disease, according to a study published March 5 in the
New England Journal of Medicine
.
March 3, 2020
Prehydration not needed before contrast CT of kidneys
By
Abraham Kim
Prehydrating patients who have chronic kidney disease before they undergo a contrast-enhanced CT exam has been the standard of care for years. But new research suggests that the practice results in unnecessary costs with few patient benefits. The findings were published online on February 17 in
JAMA Internal Medicine
.
February 17, 2020
Week in Review: Imaging helps spots coronavirus | Contrast safe for kidneys | Portable x-ray photos
By
Brian Casey
January 24, 2020
Experts reaffirm safety of contrast use for kidney CT
By
Abraham Kim
Concerns over the potential harms associated with intravenous iodinated contrast CT for kidney disease have been overstated, according to a series of consensus statements from the American College of Radiology and the National Kidney Foundation published online January 21 in
Radiology
.
January 20, 2020
Patients at risk for NSF might be safe with certain GBCAs
By
Wayne Forrest
Could certain gadolinium-based contrast agents (GBCAs) be safe for patients undergoing an MRI scan whose stage 4 or 5 chronic kidney disease puts them at risk for nephrogenic systemic fibrosis (NSF)? In some cases, the answer is yes, according to a meta-analysis published December 9 in
JAMA: Internal Medicine
.
December 19, 2019
Video from RSNA 2019: Get ready for changes to radiology billing in 2020
A host of changes in radiology billing and coding are coming in 2020 -- is your imaging facility prepared? Find out about some of the more important changes -- such as the arrival of clinical decision support -- in this video interview with Sandy Coffta of Healthcare Administrative Partners.
December 3, 2019
MRI-guided prostate cancer treatment shows promise
By
Wayne Forrest
Researchers are touting the efficacy of a new, incision-free MRI-guided procedure that uses therapeutic ultrasound to treat prostate cancer and benign enlargement of the prostate gland in a multicenter study. Findings were presented Monday at RSNA 2019 in Chicago.
December 1, 2019
MRI contrast ferumoxytol causes very few side effects
By
Wayne Forrest
Could ferumoxytol replace gadolinium-based contrast agents for some MRI scans? It is a possibility, given that it is well tolerated by patients with chronic kidney disease and caused no serious adverse events, according to a study published in the December issue of
Radiology
.
November 28, 2019
Previous Page
Page 21 of 93
Next Page